Patents by Inventor Christian Isak Joergensen
Christian Isak Joergensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230295591Abstract: Disclosed is variants of a cellulase having improved stability in the presence of a protease, and the use of such variants in laundry.Type: ApplicationFiled: January 11, 2023Publication date: September 21, 2023Applicant: Novozymes A/SInventors: Svend Gunnar Kaasgaard, Frank Winther Rasmussen, Roland Alexander Pache, Lars Anderson, Mette Louise Dissing Overgaard, Thomas Agersten Poulsen, Dorte Marie Koefoed Klitgaard, Christian Isak Joergensen, Lars Giger
-
Publication number: 20230143128Abstract: Disclosed are carbohydrate binding module variants, as well as variants of a glycoside hydrolase comprising the carbohydrate binding module variants. The variants having glycoside hydrolase activity comprising the carbohydrate binding module variants have improved stability in the presence of a protease, and are useful in detergent applications, such as laundry or dish wash.Type: ApplicationFiled: April 7, 2021Publication date: May 11, 2023Applicant: Novozymes A/SInventors: Kenneth Jensen, Lars Anderson, Svend Gunnar Kaasgaard, Jonatan Ulrik Fangel, Frank Winther Rasmussen, Pengfei Tian, Christian Isak Joergensen
-
Patent number: 11566239Abstract: Disclosed is variants of a cellulase having improved stability in the presence of a protease, and the use of such variants in laundry.Type: GrantFiled: April 12, 2019Date of Patent: January 31, 2023Assignee: Novozymes A/SInventors: Svend Gunnar Kaasgaard, Frank Winther Rasmussen, Roland Alexander Pache, Lars Anderson, Mette Louise Dissing Overgaard, Thomas Agersten Poulsen, Dorte Marie Koefoed Klitgaard, Christian Isak Joergensen, Lars Giger
-
Publication number: 20210363510Abstract: Disclosed is variants of a cellulase having improved stability in the presence of a protease, and the use of such variants in laundry.Type: ApplicationFiled: April 12, 2019Publication date: November 25, 2021Applicant: Novozymes A/SInventors: Svend Gunnar Kaasgaard, Frank Winther Rasmussen, Roland Alexander Pache, Lars Anderson, Mette Louise Dissing Overgaard, Thomas Agersten Poulsen, Dorte Marie Koefoed Klitgaard, Christian Isak Joergensen, Lars Giger
-
Patent number: 10954499Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.Type: GrantFiled: February 21, 2019Date of Patent: March 23, 2021Assignee: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Publication number: 20190177711Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.Type: ApplicationFiled: February 21, 2019Publication date: June 13, 2019Applicant: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Patent number: 10233434Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.Type: GrantFiled: October 5, 2017Date of Patent: March 19, 2019Assignee: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Publication number: 20180044650Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.Type: ApplicationFiled: October 5, 2017Publication date: February 15, 2018Applicant: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Patent number: 9822349Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides, such that the nucleic acid is operably linked to a heteroloqous control sequence for expression. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides set forth in SEQ ID NO:2 and fragments of SEQ ID NO:2.Type: GrantFiled: August 9, 2016Date of Patent: November 21, 2017Assignee: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Publication number: 20170015984Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.Type: ApplicationFiled: August 9, 2016Publication date: January 19, 2017Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Patent number: 9428741Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides, such that the nucleic acid is operably linked to a heterologous control sequence for expression. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides set forth in SEQ ID NO: 2 and fragments of SEQ ID NO: 2.Type: GrantFiled: April 7, 2015Date of Patent: August 30, 2016Assignee: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Publication number: 20150210990Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.Type: ApplicationFiled: April 7, 2015Publication date: July 30, 2015Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Patent number: 8383391Abstract: This disclosure relates to mutant cells with deleted or disrupted genes encoding protease(s).Type: GrantFiled: September 30, 2008Date of Patent: February 26, 2013Assignee: Novozymes A/SInventors: Hiroaki Udagawa, Christian Isak Jørgensen
-
Patent number: 8288510Abstract: The invention provides for isolated peptides having phospholipase inhibitory activity, polypeptides comprising phospholipase inhibitory activity and lipases capable of being inhibited by the isolated peptides and/or polypeptides comprising phospholipase inhibitory activity. The invention also relates to nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides as well as methods for producing and using the peptides and the polypeptides having lipase inhibitory activity.Type: GrantFiled: April 30, 2009Date of Patent: October 16, 2012Assignee: Novozymes A/SInventors: Leonardo de Naria, Ming Li, Christian Isak Joergensen, Kim Borch, Tom Anton Busk Nielsen, Jesper Vind
-
Patent number: 7993890Abstract: The present invention relates to a process for enzymatic hydrolysis of arabinoxylan, and an enzyme composition suitable for use in such a process.Type: GrantFiled: April 25, 2006Date of Patent: August 9, 2011Assignee: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Sven Pedersen, Anders Viksoe-Nielsen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Publication number: 20100304433Abstract: The present invention relates to isolated polypeptides having protease activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.Type: ApplicationFiled: September 30, 2008Publication date: December 2, 2010Applicant: Novozymes A/SInventors: Hiroaki Udagawa, Christian Isak Jørgensen
-
Publication number: 20090275083Abstract: The invention provides for isolated peptides having phospholipase inhibitory activity, polypeptides comprising phospholipase inhibitory activity and lipases capable of being inhibited by the isolated peptides and/or polypeptides comprising phospholipase inhibitory activity. The invention also relates to nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides as well as methods for producing and using the peptides and the polypeptides having lipase inhibitory activity.Type: ApplicationFiled: April 30, 2009Publication date: November 5, 2009Applicant: Novozymes A/SInventors: Leonardo De Maria, Ming Li, Christian Isak Joergensen, Kim Borch, Tom Anton Busk Nielsen, Jesper Vind
-
Publication number: 20090136476Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.Type: ApplicationFiled: April 25, 2006Publication date: May 28, 2009Applicant: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
-
Publication number: 20080274527Abstract: The present invention relates to a process for enzymatic hydrolysis of arabinoxylan, and an enzyme composition suitable for use in such a process.Type: ApplicationFiled: April 25, 2006Publication date: November 6, 2008Applicant: Novozymes A/SInventors: Hanne Risbjerg Soerensen, Sven Pedersen, Anders Viksoe-Nielsen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod